Allena Pharmaceuticals, Inc. ALNA
Set alert
0.08 +0.08 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 0
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -1.07
- Beta
- 1.15
- Short ratio
- 0.62
- Inst. own
- 7.42%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 15, 2022
- 50-d avg
- 0.124116
- 200-d avg
- 0.276548
- 1y target
- 4.00
Analyst view
Consensus: hold
Hold
Price target (mean) 4.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy2
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 3
- 2 months ago 3
- 3 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.05 | -0.05 – -0.05 | -0.17 | +70.6% | 0 | 0.0% | 1 |
| Next quarter | -0.04 | -0.04 – -0.04 | -0.11 | +63.6% | 0 | 0.0% | 1 |
| Current year | -0.25 | -0.25 – -0.25 | -0.72 | +65.3% | 0 | 0.0% | 1 |
| Next year | -0.07 | -0.07 – -0.07 | -0.25 | +72.0% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 22, 2022 | B. Riley Securities | Downgrade | Buy | Neutral |
| Mar 21, 2022 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Mar 21, 2022 | Ladenburg Thalmann | Downgrade | Buy | Neutral |
| Jun 1, 2020 | HC Wainwright & Co. | Initiated | — | Buy |
| Mar 18, 2020 | B. Riley FBR | Maintained | — | Buy |
| Mar 13, 2020 | B. Riley FBR | Maintained | — | Buy |
| Nov 8, 2019 | Credit Suisse | Downgrade | Outperform | Neutral |
| Sep 6, 2019 | Credit Suisse | Maintained | — | Outperform |
| Jan 18, 2019 | Baird | Initiated | — | Outperform |
| Aug 8, 2018 | B. Riley FBR | Maintained | Buy | Buy |
| Aug 2, 2018 | Ladenburg Thalmann | Initiated | — | Buy |
| May 5, 2018 | B. Riley FBR | Initiated | — | Buy |
| Apr 2, 2018 | Roth Capital | Initiated | — | Buy |
| Mar 28, 2018 | Credit Suisse | Maintained | Outperform | Outperform |
| Nov 27, 2017 | Cowen & Co. | Initiated | — | Outperform |
| Nov 27, 2017 | Wedbush | Initiated | — | Outperform |
| Nov 27, 2017 | Credit Suisse | Initiated | — | Outperform |
| Nov 27, 2017 | Jefferies | Initiated | — | Buy |